Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of British Columbia
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Identified MS cohort with hospital/physician and prescription claims classified according to the international classification of disease codes and drug identification numbers respectively, using a validated case definition. This case definition requires an individual to have at least three health care encounters (any combination of inpatient encounter, outpatient encounter, or DMT dispensation) for MS in a 1-year window
MS patients who initiated and used fingolimod, natalizumab, alemtuzumab, dimethyl fumarate, or teriflunomide as monotherapy following MS identification.
You may not be if
Pediatric (\<18 years old) MS cases.
MS cases with less than three years of baseline data before the first drug dispensation.
MS cases with skin cancer in the three-year baseline period
